These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17499541)

  • 41. Sex-specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus.
    Kautzky-Willer A; Kamyar MR; Gerhat D; Handisurya A; Stemer G; Hudson S; Luger A; Lemmens-Gruber R
    Gend Med; 2010 Dec; 7(6):571-83. PubMed ID: 21195357
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Earlier triple therapy with pioglitazone in patients with type 2 diabetes.
    Charpentier G; Halimi S;
    Diabetes Obes Metab; 2009 Sep; 11(9):844-54. PubMed ID: 19614944
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The longitudinal association between glycaemic control and health-related quality of life following insulin therapy optimisation in type 2 diabetes patients. A prospective observational study in secondary care.
    Hajos TR; Pouwer F; de Grooth R; Holleman F; Twisk JW; Diamant M; Snoek FJ
    Qual Life Res; 2012 Oct; 21(8):1359-65. PubMed ID: 22065281
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduction in glycated albumin can predict change in HbA1c: comparison of oral hypoglycaemic agent and insulin treatments.
    Won HK; Kim KJ; Lee BW; Kang ES; Cha BS; Lee HC
    Diabet Med; 2012 Jan; 29(1):74-9. PubMed ID: 21781151
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.
    Barnett AH; Burger J; Johns D; Brodows R; Kendall DM; Roberts A; Trautmann ME
    Clin Ther; 2007 Nov; 29(11):2333-48. PubMed ID: 18158075
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).
    Murata GH; Shah JH; Hoffman RM; Wendel CS; Adam KD; Solvas PA; Bokhari SU; Duckworth WC;
    Diabetes Care; 2003 Jun; 26(6):1759-63. PubMed ID: 12766106
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).
    Raskin P; Matfin G; Schwartz SL; Chaykin L; Chu PL; Braceras R; Wynne A
    Diabetes Obes Metab; 2009 Jan; 11(1):27-32. PubMed ID: 17941873
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biphasic insulin aspart 30 treatment in patients with type 2 diabetes poorly controlled on prior diabetes treatment: results from the PRESENT study.
    Sharma SK; Al-Mustafa M; Oh SJ; Azar ST; Shestakova M; Guler S; Vaz JA
    Curr Med Res Opin; 2008 Mar; 24(3):645-52. PubMed ID: 18215338
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes.
    Harris MI;
    Diabetes Care; 2001 Jun; 24(6):979-82. PubMed ID: 11375356
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Longitudinal association between medication adherence and glycaemic control in Type 2 diabetes.
    Aikens JE; Piette JD
    Diabet Med; 2013 Mar; 30(3):338-44. PubMed ID: 23075262
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biphasic insulin aspart 30 plus metformin: an effective combination in type 2 diabetes.
    Kvapil M; Swatko A; Hilberg C; Shestakova M
    Diabetes Obes Metab; 2006 Jan; 8(1):39-48. PubMed ID: 16367881
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ethnic differences in glycaemic control in adult Type 2 diabetic patients in primary care: a 3-year follow-up study.
    Ng TP; Goh LG; Tan Y; Tan E; Leong H; Tay EG; Thai AC
    Diabet Med; 2005 Nov; 22(11):1598-604. PubMed ID: 16241927
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insulin lispro protamine suspension in intensive insulin treatment: an Italian observational study.
    Citro G; Lorusso B; Rossi A; Romaniello M; Gentilella R; Cremasco F
    Curr Med Res Opin; 2009 Sep; 25(9):2259-65. PubMed ID: 19630489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Markers of inflammation in patients with coronary artery disease are also associated with glycosylated haemoglobin A1c within the normal range.
    Gustavsson CG; Agardh CD
    Eur Heart J; 2004 Dec; 25(23):2120-4. PubMed ID: 15571827
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between mean blood glucose and glycated haemoglobin in Type 2 diabetic patients.
    Makris K; Spanou L; Rambaouni-Antoneli A; Koniari K; Drakopoulos I; Rizos D; Haliassos A
    Diabet Med; 2008 Feb; 25(2):174-8. PubMed ID: 18290858
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes.
    Albarracin CA; Fuqua BC; Evans JL; Goldfine ID
    Diabetes Metab Res Rev; 2008; 24(1):41-51. PubMed ID: 17506119
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of insulin and oral anti-diabetic agents on glucose metabolism, vascular dysfunction and skeletal muscle inflammation in type 2 diabetic subjects.
    Joya-Galeana J; Fernandez M; Cervera A; Reyna S; Ghosh S; Triplitt C; Musi N; DeFronzo RA; Cersosimo E
    Diabetes Metab Res Rev; 2011 May; 27(4):373-82. PubMed ID: 21309063
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictive characteristics of patients achieving glycaemic control with insulin after sulfonylurea failure.
    Lee YH; Lee BW; Chun SW; Cha BS; Lee HC
    Int J Clin Pract; 2011 Oct; 65(10):1076-84. PubMed ID: 21923847
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes.
    Fonseca V; Schweizer A; Albrecht D; Baron MA; Chang I; Dejager S
    Diabetologia; 2007 Jun; 50(6):1148-55. PubMed ID: 17387446
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug titration patterns and HbA 1c levels in type 2 diabetes.
    Maclean JR; Chapman RH; Ferrufino CP; Krishnarajah G
    Int J Clin Pract; 2009 Jul; 63(7):1008-16. PubMed ID: 19570118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.